Protalix Biotherapeutics Inc. sell dimontalban
Start price
04.04.22
/
40%
€1.76
Target price
04.04.23
€0.000
Performance (%)
-35.27%
End price
02.06.22
€1.14
Summary
This prediction ended on 02.06.22 with a price of €1.14. dimontalban correctly predicted massive losses of -35.27% for Protalix Biotherapeutics Inc.. dimontalban has 40% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Protalix Biotherapeutics Inc. | 12.912% | 12.912% | -45.965% |
| iShares Core DAX® | -3.429% | 5.085% | 15.455% |
| iShares Nasdaq 100 | -6.121% | 0.593% | 16.379% |
| iShares Nikkei 225® | -7.364% | 5.479% | 6.970% |
| iShares S&P 500 | -4.366% | 2.019% | 18.650% |
According to dimontalban what are the pros and cons of Protalix Biotherapeutics Inc. for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Good culture
Capable Management
Leading role in innovation
Future proof or reliable business model
Sustainability is important
Cons
Revenue decline/stagnation expected
EBIT decline > 20% expected
overvalued
negative Cash Flow expected
Junk rating
Very little Investments for future growth
Risky balance sheet
ROE lower than 10% per year
Few uniques
Growths much slower than the competition
Mainly gamblers invest here
High risks for its business
Below average Marketposition
Very high cyclical dependencies
Little known brand
Decining EBIT margin than peer group
Low dividend yield expected
High challenges to pay loans and raise capital
Dependend from few customers or products
Comments by dimontalban for this prediction
In the thread Protalix Biotherapeutics Inc. diskutieren
Sell mit Kursziel 0,0